Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Third Edition BOGP (10)
United Kingdom (3)
Advocacy (policy advocacy, lobbying)
Pharmaceutical Company (9)
Regulators
Representativeness of stakeholders
Clinical study phase III